GLP1-S improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity
Orforglipron had a similar safety profile as other GLP-1 receptor agonists. Trial outcomes For ATTAIN-2, researchers enrolled 1,613 adults aged 18 years and older with obesity or overweight plus one weight-related comorbidity, and with type 2 diabetes with an HbA1c between 7% and 10% at baseline (mean age, 56.8 years
Both GL and 3MGA are subsequently transported into bile via canalicular efflux transporters, including multidrug resistance-associated protein 2 (MRP2), breast cancer resistance protein (BCRP), and bile salt export pump (BSEP) (Makino et al., 2008)
This article examines the clinical evidence, potential risks, safe drinking guidelines, and situations requiring complete alcohol avoidance for patients taking semaglutide